DURECT To Present At Merriman Curhan Ford’s Annual Investor Summit
Cupertino, CA-
September 11, 2007
CUPERTINO, CA – September 11, 2007 – PRNewswire-First Call via COMTEX/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Felix Theeuwes, Chairman and CSO, will present at the 4th annual Merriman Curhan Ford & Co. Investor Summit on September 17, 2007 at 11:45 a.m. Pacific Time. This event will be held at the Mark Hopkins InterContinental Hotel in San Francisco. More information about the conference can be found at: www.merrimanco.com
A live audio webcast of the presentation will be available by accessing DURECT’s homepage at www.durect.com and clicking “Investor Relations.” If you are unable to participate during the live webcast, the call will be archived on DURECT’s website under Audio Archive in the “Investor Relations” section.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit www.durect.com.
SOURCE: DURECT Corporation CONTACT: Matthew J. Hogan, Chief Financial Officer, 408-777-4936
|
|
